These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 16041289)
21. Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease. Piguet O; Halliday GM; Creasey H; Broe GA; Kril JJ Int Psychogeriatr; 2009 Aug; 21(4):688-95. PubMed ID: 19493380 [TBL] [Abstract][Full Text] [Related]
22. Imaging of the aging brain. Part II. Pathologic conditions. Drayer BP Radiology; 1988 Mar; 166(3):797-806. PubMed ID: 3277248 [TBL] [Abstract][Full Text] [Related]
23. [Brain imaging--a support in the investigation of dementia]. Van Westen D; Ryding E; Santillo AF Lakartidningen; 2009 May 13-19; 106(20):1390-5. PubMed ID: 19585837 [No Abstract] [Full Text] [Related]
24. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. Jobst KA; Barnetson LP; Shepstone BJ Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148 [TBL] [Abstract][Full Text] [Related]
25. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Beyer MK; Larsen JP; Aarsland D Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706 [TBL] [Abstract][Full Text] [Related]
26. Dementia with Lewy bodies: diagnosis and management. Barber R; Panikkar A; McKeith IG Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S12-8. PubMed ID: 11748785 [TBL] [Abstract][Full Text] [Related]
27. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging. Jobst KA; Barnetson LP; Shepstone BJ Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442 [TBL] [Abstract][Full Text] [Related]
28. Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging. Bastos Leite AJ; van Straaten EC; Scheltens P; Lycklama G; Barkhof F Stroke; 2004 Feb; 35(2):415-9. PubMed ID: 14726554 [TBL] [Abstract][Full Text] [Related]
29. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292 [TBL] [Abstract][Full Text] [Related]
30. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. Tanna NK; Kohn MI; Horwich DN; Jolles PR; Zimmerman RA; Alves WM; Alavi A Radiology; 1991 Jan; 178(1):123-30. PubMed ID: 1984290 [TBL] [Abstract][Full Text] [Related]
31. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Barber R; McKeith I; Ballard C; O'Brien J J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):406-7. PubMed ID: 11861709 [TBL] [Abstract][Full Text] [Related]
33. Neuroimaging in Alzheimer disease: an evidence-based review. Kantarci K; Jack CR Neuroimaging Clin N Am; 2003 May; 13(2):197-209. PubMed ID: 13677801 [TBL] [Abstract][Full Text] [Related]
34. [Differential diagnosis of Alzheimer-type dementia and vascular dementia based on neuroimaging study]. Hanyu H; Nakano S; Abe S; Arai H; Iwamoto T; Takasaki M No To Shinkei; 1995 Jul; 47(7):665-70. PubMed ID: 7612383 [TBL] [Abstract][Full Text] [Related]
35. Neuropathological basis of magnetic resonance images in aging and dementia. Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909 [TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance approaches to brain aging and Alzheimer disease-associated neuropathology. Anderson VC; Litvack ZN; Kaye JA Top Magn Reson Imaging; 2005 Dec; 16(6):439-52. PubMed ID: 17088693 [TBL] [Abstract][Full Text] [Related]
37. The Value of Neuroimaging in Dementia Diagnosis. Raji CA; Benzinger TLS Continuum (Minneap Minn); 2022 Jun; 28(3):800-821. PubMed ID: 35678403 [TBL] [Abstract][Full Text] [Related]
38. Dementia with Lewy bodies. McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332 [TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and treatment of mixed dementia]. Hanyu H Brain Nerve; 2012 Sep; 64(9):1047-55. PubMed ID: 22941841 [TBL] [Abstract][Full Text] [Related]
40. Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies. Mak E; Su L; Williams GB; Watson R; Firbank M; Blamire AM; O'Brien JT Neuroimage Clin; 2015; 7():456-62. PubMed ID: 25685712 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]